Verastem, Inc. (NASDAQ:VSTM) is developing small molecule inhibitors of signaling pathways that are critical to cancer stem cell survival and proliferation. The company’s current product line includes: FAK, PI3K/mTOR and Wnt. Verastem’s proprietary research has developed a system for the … Continue reading →

VBI Vaccines, Inc. (NASDAQ:VBIV) is a biopharmaceutical company developing novel technologies that seek to expand vaccine protection in large underserved markets. VBI’s lead eVLP asset is a prophylactic Cytomegalovirus (“CMV”) vaccine. The company has initiated work for GMP manufacturing of … Continue reading →

Uranium Energy Corp. (NYSE: UEC) is a U.S.-based uranium mining and exploration company with a  fully-licensed Hobson processing plant as the central point of all of its projects in South Texas, including the Palangana in-situ recovery (ISR) mine, the permitted … Continue reading →

Ur-Energy, Inc. (NYSE: URG) is a uranium mining company operating the Lost Creek in-situ recovery uranium facility in south-central Wyoming. The Lost Creek processing facility has a two million pounds per year nameplate design capacity. Shirley Basin, our newest project, … Continue reading →

UQM Technologies Inc. (NYSE: UQM) develops and manufactures power-dense, high-efficiency electric motors, generators, power electronic controllers and fuel cell compressors for the commercial truck, bus, automotive, marine, military and industrial markets. A major emphasis for UQM is developing propulsion systems … Continue reading →

uniQure N.V. (NASDAQ:QURE) participates in the field of gene therapy and has developed the first and currently the only gene therapy product to receive regulatory approval in the European Union. The company is developing a pipeline of adeno-associated virus (AAV)-based … Continue reading →

US Physical Therapy, Inc. (NYSE: USPH) operates 503 clinics in 42 states to provide preventative and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, treatment for neurologically-related injuries, and rehabilitation of injured workers. In addition to owning … Continue reading →

TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) develops targeted therapies for cancer, wet AMD and fibrotic diseases. The company’s current pipeline includes two clinical stage product candidates: TRC105, an anti-endoglin antibody that is being developed for the treatment of renal cell carcinoma, soft … Continue reading →

Top Image Systems™ Ltd. (NASDAQ:TISA) provides enterprise solutions for capturing and validating structured and unstructured content entering organizations from various sources and managing content-driven business processes. Whether originating from mobile, electronic, paper or other sources, TIS solutions automatically capture, process … Continue reading →

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) is focused on the invention and development of novel pharmaceutical products for medical conditions that it believes have broad societal impact, and that are not well served by currently available therapies. Tonix’s Tonmya™ is currently … Continue reading →